Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bionpharma
AddedFeb 15, 2024
UpdatedJun 18, 2026
Bionpharma

Bionpharma

Series A

BionPharma: Developing and commercializing affordable, quality generic drugs through effective partnerships.

HQ
Princeton, NJ, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

BionPharma, founded with a mission to develop and commercialize affordable, quality generic drugs, focuses on building strong and effective partnerships within the pharmaceutical industry. The company aims to empower its employees to engage with customers and partners, ensuring the execution of its business goals. BionPharma's product line includes a range of generic medications designed to provide cost-effective alternatives to brand-name drugs, targeting a broad market of healthcare providers and consumers seeking affordable medication options.

Notable figures affiliated with BionPharma include industry veterans who bring extensive experience in pharmaceutical development and commercialization. The company has achieved significant milestones in expanding its product portfolio and establishing key partnerships that enhance its market presence. BionPharma's impact is evident in its contribution to making essential medications more accessible and affordable, thereby improving healthcare outcomes for a wide range of patients.

Bionpharma - Similar Companies

Solaris Pharma logo

Solaris Pharma

solaris-pharma.com

Leading Pharma logo

Leading Pharma

leadingpharma.com

Pyros Pharmaceuticals logo

Pyros Pharmaceuticals

pyrospharma.com

G2B Pharma logo

G2B Pharma

BioQ Pharma logo

BioQ Pharma

bioqpharma.com

Bioscience Pharma Partners logo

Bioscience Pharma Partners

Meitheal Pharmaceuticals logo

Meitheal Pharmaceuticals

meithealpharma.com

Genzum Life Sciences logo

Genzum Life Sciences

genzum.com

Sinogen Biopharma logo

Sinogen Biopharma

BiotechInnova logo

BiotechInnova

biotechinnova.com

PleoPharma logo

PleoPharma

pleopharma.com

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Coeptis Pharmaceuticals logo

Coeptis Pharmaceuticals

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

OurPharma Holdings logo

OurPharma Holdings

ourpharma.net

Bionpharma - Quick Facts

Who are Bionpharma's competitors?

Companies similar to Bionpharma include Solaris Pharma, Leading Pharma, Pyros Pharmaceuticals and G2B Pharma.

When was Bionpharma founded?

Bionpharma was founded in 2014.

Where is Bionpharma's headquarters located?

Bionpharma's headquarters is located in Princeton, NJ, US.

When was Bionpharma's last funding round?

Bionpharma's most recent funding round was for $6.5M (USD) in December 2015.

How much has Bionpharma raised to-date?

As of Dec 14, 2015, Bionpharma has raised a total of $58.2M (USD).

How many employees does Bionpharma have?

Bionpharma has 36 employees as of Feb 5, 2024.

Bionpharma - Classification

Ownership
  • Private
Technology
  • SaaS
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring Transactional
Main Product
  • Generic Drugs
Tags
  • Enterprise Government
  • Pharmaceuticals
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified